Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Ambrogio

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Nature Reviews. Cancer|December 22, 2007
The anaplastic lymphoma kinase in the pathogenesis of cancerRoberto Chiarle, Claudia Voena, Chiara Ambrogio, et al.
Biotechniques|October 15, 2014
Lentiviral-based approach for the validation of cancer therapeutic targets in vivoChiara Ambrogio, Patrick Stern, Claudio Scuoppo, et al.
The Journal of Biological Chemistry|June 18, 2010
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growthLudovica Riera, Elena Lasorsa, Chiara Ambrogio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus TrametinibDaniel L Abravanel, Mizuki Nishino, Lynette M Sholl, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
European Journal of Cell Biology|May 8, 2012
PPP4R2 regulates neuronal cell differentiation and survival, functionally cooperating with SMNYlenia Bosio, Gaia Berto, Paola Camera, et al.
ESMO Open|November 16, 2016
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapyChiara Ambrogio, Ernest Nadal, Alberto Villanueva, et al.
Journal of Cell Science|October 19, 2023
Correction: The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinaseGaia Berto, Paola Camera, Carlo Fusco, et al.
Journal of Cell Science|May 10, 2007
The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinaseGaia Berto, Paola Camera, Carlo Fusco, et al.
Molecular Oncology|February 16, 2024
Novel RAF-directed approaches to overcome current clinical limits and block the RAS/RAF nodeRossella Scardaci, Ewa Berlinska, Pietro Scaparone, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Nature Reviews. Cancer|December 22, 2007
The anaplastic lymphoma kinase in the pathogenesis of cancerRoberto Chiarle, Claudia Voena, Chiara Ambrogio, et al.
Biotechniques|October 15, 2014
Lentiviral-based approach for the validation of cancer therapeutic targets in vivoChiara Ambrogio, Patrick Stern, Claudio Scuoppo, et al.
The Journal of Biological Chemistry|June 18, 2010
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growthLudovica Riera, Elena Lasorsa, Chiara Ambrogio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus TrametinibDaniel L Abravanel, Mizuki Nishino, Lynette M Sholl, et al.
Nature Medicine|May 13, 2008
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccinationRoberto Chiarle, Cinzia Martinengo, Cristina Mastini, et al.
European Journal of Cell Biology|May 8, 2012
PPP4R2 regulates neuronal cell differentiation and survival, functionally cooperating with SMNYlenia Bosio, Gaia Berto, Paola Camera, et al.
ESMO Open|November 16, 2016
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapyChiara Ambrogio, Ernest Nadal, Alberto Villanueva, et al.
Journal of Cell Science|October 19, 2023
Correction: The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinaseGaia Berto, Paola Camera, Carlo Fusco, et al.
Journal of Cell Science|May 10, 2007
The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinaseGaia Berto, Paola Camera, Carlo Fusco, et al.
Molecular Oncology|February 16, 2024
Novel RAF-directed approaches to overcome current clinical limits and block the RAS/RAF nodeRossella Scardaci, Ewa Berlinska, Pietro Scaparone, et al.
Pageof 9